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ABSTRACT

FUNCTIONAL IMPLICATIONS OF NLRP1 VARIANTS FOR AUTOIMMUNE
DISEASE
Laura Jane Westhoff
Department of Microbiology and Molecular Biology
Bachelor of Science

NLRP1 is a protein-coding human gene that plays a crucial role in the NLRP1
inflammasome. Variants to the NLRP1 gene have been associated with autoimmune and
autoinflammatory diseases. We examined the effects of polymorphisms at two SNPs on
cytokine levels and NLRP1 gene expression in 50 human volunteers without diagnosed
autoimmune disease. NLRP1 was genotyped at SNPs rs2670660 and rs12150220 and
individuals who were homozygous at one or more SNP were selected for further analysis.
Serum IL-18 and IL-1β levels were quantified using ELISA. NLRP1 gene expression was
measured using real-time PCR. A strong linkage was found between genotypes of
rs2670660 and rs12150220 (p = 2.33 x 10-13). Participants with an AAAA genotype
(written as rs2670660 genotype + rs12150220 genotype) had significantly higher levels
of IL-18 than participants with a GGTT genotype (0.439 ng/µL vs 0.152 ng/µL, p =
0.024). A trend towards increased NLRP1 expression was seen in the AAAA genotype
(4.392-fold increase, p = 0.101). It is likely that the AAAA genotype represents a
combination of two homozygous autoimmunity risk variants. The AAAA genotype
showed increased production of IL-18 even in non-autoimmune individuals, with a trend
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towards higher gene expression, suggesting that the AA variants of rs2670660 and
rs12150220 lead to increased NLRP1 activity. Due to the linkage of rs2670660 and
rs12150220, it was impossible to differentiate which SNP was responsible for the
observed effects. Further studies with a larger sample size would contribute to an
increased understanding of the effects of NLRP1 variants on autoimmune disease.
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BACKGROUND
Autoimmune diseases are a group of more than 80 chronic illnesses that can affect
almost any system, organ, or tissue in the body. Often acquired with age and always noncontagious, these disorders are difficult to treat because they are caused by immune
system attacks on the body’s own tissues and cells. Of significant concern to the field of
healthcare, autoimmune diseases affect between 14.7 and 23.5 million Americans [1].
The NLRP1, or NALP1, gene is a protein-coding human gene found on
chromosome 17. The NLRP1 protein plays a crucial role in the nucleotide-binding
domain leucine-rich repeat containing (NLR) inflammasome. NLRP1 is the sensor
protein; when activated it recruits caspase-1 to initiate inflammasome assembly.
Inflammasomes are multiprotein oligomers responsible for the inflammatory responses
that are essential to the innate immune system [2]. Components and homologues of the
NLRP1 inflammasome have been implicated in many autoinflammatory diseases,
examples of which include inflammatory bowel disease, Blau syndrome, Muckle-Wells
syndrome, and neonatal onset multisystem inflammatory disease [3-6]. However, another
subset of research has found a strong epidemiological correlation between NLRP1
polymorphisms and vitiligo, an autoimmune disease causing loss of skin pigmentation,
especially when vitiligo is presented in concert with other autoimmune diseases including
autoimmune thyroid disease, latent autoimmune diabetes in adults, rheumatoid arthritis,
psoriasis, pernicious anemia, systemic lupus erythematosus, and Addison's disease [7-9].
This connection between NLRP1 and vitiligo-associated autoimmune disease is
especially fascinating given the usual separation in the categorization of autoimmune and
autoinflammatory diseases. Autoinflammatory diseases are caused by a self-induced

1

increase in inflammation, whereas autoimmune diseases are caused by the weaponization
of the body’s immune system against its own cells. The NLR pathway is an innate
immune pathway, meaning it is usually associated with only autoinflammatory diseases.
Thus, NLRP1’s association with autoimmune diseases, which are usually associated with
adaptive immunity, presents a compelling research interest [10].
NLRP1 has been implicated in the secretion of interleukin 1 beta (IL-1β) and the
secretion of interleukin 18 (IL-18) [11-14]. IL-1β and IL-18 are structurally and
functionally similar [15]. They are produced as biologically inactive precursors, which
are then cleaved and thereby activated by caspase-1 [16]. The secretion of these
interleukins may be connected to the development of autoimmune diseases; for example,
IL-18 has been postulated to play a role in the autoimmune disease Hashimoto’s
thyroiditis, and is found in higher than average levels in patients with rheumatoid arthritis
and systemic lupus erythematosus, among others [17-19]. Human NLRP1 variants
associated with autoimmune diseases have been identified in meta-analysis and
epidemiological studies, and the general mechanisms of the NLR pathway have been
identified [2, 7, 8]. In their foundational 2007 study on NLRP1 and vitiligo-associated
autoimmune disease, Jin et al. identified 19 SNPs that were associated with autoimmune
and autoinflammatory diseases, including rs12150200 and rs2670660. rs12150220 is an
L115H substitution located in the protein-coding region of NLRP1, while rs2670660 is
located in the promoter region (Figure 1) [7, 12]. The segment in which rs2670660 is
located is conserved in several mammals, suggesting that it has functional importance.
This area of the promoter changes predicted binding motifs for the transcriptional factors
MYB and HMGA1, with MYB regulating transcription during differentiation,
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proliferation, and apoptosis of lymphoid, myeloid, and erythroid cell lines [7]. Despite
the interesting potential effects of variations to rs2670660, rs12150220 has been studied
more extensively for its effects on autoimmune disease [11, 20, 21]. The current literature
lacks consensus on the effects of rs2670660 on mRNA expression, cytokine expression,
or protein function of NLRP1, and neither SNP has been explicitly tested for effects on
IL-18 expression [12]. Therefore, the purpose of this study was to characterize the effects
of two specific NLRP1 gene variants, at SNPs rs2670660 and rs12150220, on NLRP1
mRNA transcription levels and IL-1β and IL-18 secretion, to determine the differential
roles of NLRP1 polymorphisms and their implications on autoimmune disease.

Figure 1. Visual representation of the NLRP1 inflammasome, indicating location of rs12150220.
Domains of the human NLRP1 inflammasome and the eventual activation of IL-1β and IL-18 by caspase-1
are shown. The location of rs12150220 is marked (*), representing a nonsynonymous L155H substitution.
The location of rs2670660 is not indicated because the architecture of the NLRP1 promoter region is less
well-characterized. Adapted from Yu et al. (2018).
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MATERIALS AND METHODS
Experimental design overview
Blood samples were recruited from participants and processed to prepare for
further analyses. DNA was isolated from whole blood for genotyping and ELISAs were
performed using plasma. RNA was extracted from lymphocytes, used to produce cDNA,
and analyzed using qPCR. All samples were genotyped at both SNPs (rs2670660 and
rs12150220), but only samples with at least one homozygous locus were selected for
further testing. Figure 2 provides a visual organization of the main tests performed for
this analysis.
Selection of participants
The presence of homozygous genotypes at both SNPs has been shown in control
populations—18% and 32% for rs2670660 and 17% and 36% for rs12150220 according
to one study—despite an absence of autoimmune disease presentation [22]. For this
project, we did not have access to a population of patients with vitiligo-associated
autoimmune disease. As such, we analyzed the effects of risk variants in a population
without diagnosed autoimmune disease, anticipating that the high presence of risk
variants would still cause a change to mRNA transcription or interleukin levels. If NLRP1
variants are only one contributing factor to autoimmune disease presentation, it is
possible that functional effects of these variants can be detected in the absence of
diagnosed autoimmune disease. Vitiligo and other associated autoimmune diseases tend
to be polygenic, so by using participants without a diagnosed autoimmune disease we
attempted to eliminate the confounding influence of other genes associated with risk
variants for autoimmune disease, such as PTPN22 in vitiligo-associated autoimmunity, or
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IRF5 in systemic lupus erythematosus [9, 23]. It is, of course, possible that our
participants had these or other autoimmunity risk variants in addition to NLRP1 variants.
Blood sample
collection
N = 50

Genotyping
N = 50

Homozygous at 1
or both SNPs
N = 25

IL-18 ELISA
N = 25

Heterozygous at
both SNPs
N = 25

IL-1β ELISA
N = 25

cDNA synthesis
N = 25

NLRP1 qPCR
N = 24

Figure 2. Visual overview of main experimental steps.

Blood collection
Participants without a diagnosed autoimmune disease were recruited by flyer and
word-of-mouth and reimbursed $15 for their donation. This sample collection was
approved by the IRB of Brigham Young University for the period of March 8th, 2019 to
March 7th, 2020. Up to 24 mL of blood were drawn by certified phlebotomists into BD
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Vacutainer™ tubes with either K2 EDTA or ACD Solution B anti-coagulant. Blood was
stored at room temperature until processed. All samples were processed within 22 hours
of collection.
Blood processing
Blood samples were centrifuged at 200 rcf for 10 minutes to separate plasma from
red blood cells. 1 mL of plasma was extracted from each sample and placed in a 1.5 mL
microcentrifuge tube to be stored at -80° C for later cytokine analysis. Blood was then
agitated and 250 µL of whole blood placed in a 1.5 mL microcentrifuge tube to be stored
at -80° C for later DNA extraction. For lymphocyte extraction, 10 mL of Corning
Lymphocyte Separation Medium was placed in a 50 mL conical tube. Then, 10 mL of the
remaining sample blood was carefully added to form a layer on top of the separation
medium. 10 m L of PBS was then added in the same manner. The 50 mL tube was
centrifuged at 400 rcf for 30 minutes, adding up to 15 more minutes if a distinct
lymphocyte layer was not visible after 30 minutes. As much as possible of the
lymphocyte layer (usually 5-10 mL) was then extracted and moved to a new 50 mL
conical tube, which was filled to 40 mL with PBS. This was centrifuged at 300 rcf for 5
minutes. The liquid was decanted and disposed of and the cell pellet maintained in the
tube. 350 mL of Ambion® RNAqueous® Lysis/Binding Solution was added to the cell
pellet. 500 mL of lysed cell matter was then transferred into a 1.5 mL microcentrifuge
tube to be stored at -80° C for later RNA isolation.
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DNA isolation
DNA was isolated from whole blood samples using Qiagen DNeasy® Blood &
Tissue Kit, following the manufacturer’s protocol. Quality of isolated DNA was
confirmed using Thermo Scientific™ NanoDrop™ Lite Spectrophotometer.
Genotyping
Genotyping was performed with Applied Biosystems™ TaqMan® SNP
Genotyping Assays for rs2670660 and rs12150220 following the manufacturer’s
protocol. Applied Biosystems™ MicroAmp® Fast Optical 96-Well Reaction Plate with
Barcode (0.1mL) was used with Applied Biosystems™ StepOnePlus™ Real-Time PCR
System and StepOne™ Software v2.3 was used for experimental design and analysis.
SNP rs2670660 has A/G variants, and SNP rs12150220 has A/T variants. For some
analyses, genotypes of rs2670660 and rs12150220 are combined into one conglomerate
genotype; for example, genotype AAGT represents an individual with the genotype AA
at rs2670660 and the genotype GT at rs12150220.
ELISA
Plasma was used for IL-1β and IL-18 ELISA analysis. IL-18 analysis was
performed using eBioscience™ Human IL-18 Platinum ELISA Kit, following the
manufacturer’s protocol. IL-1β analysis was performed using Invitrogen Human IL-1beta
Uncoated ELISA Kit, following the manufacturer’s protocol.
RNA isolation
RNA was isolated using Invitrogen RNAqueous™ Phenol-free total RNA
Isolation kit following the manufacturer’s protocol. RNA concentration was measured for
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calibrating future cDNA synthesis using Thermo Scientific™ NanoDrop™ Lite
Spectrophotometer.
cDNA synthesis
cDNA was synthesized from total RNA using Invitrogen SuperScript™ IV FirstStrand Synthesis System and Eppendorf Mastercycler® Nexus thermal cycler, following
the manufacturer’s protocols. Oligo dT primers were selected in order to isolate mRNA.
NLRP1 qPCR
We designed custom PCR primers for NLRP1 and ordered them from Integrated
DNA Technologies. Primers spanned the exon-exon junction created by the splicing of
the first intron of the NLRP1 gene to select for the amplification of mature mRNA and
exclude DNA. Forward primer sequence: CTACGTTGGCCACTTGGGAT. Reverse
primer sequence: AGGTGAAGGTACGGCTATGC. Real-time PCR was performed on
NLRP1 cDNA with GAPDH endogenous controls using Applied Biosystems™
PowerSYBR® Green PCR Master Mix following the manufacturer’s protocol. Applied
Biosystems™ MicroAmp® Fast Optical 96-Well Reaction Plate with Barcode (0.1mL)
was used with Applied Biosystems™ StepOnePlus™ Real-Time PCR System and
StepOne™ Software v2.3 was used for experimental design and analysis. Significance
threshold was set above the background in the linear portion of the amplification curve
(∆Rn = 0.048564). Ct values denote at which cycle of the PCR procedure a sample’s
amplification crossed the significance threshold. Lower Ct values represent higher gene
expression because a higher concentration of target RNA will begin to amplify earlier in
the PCR procedure. ∆Ct values are a subtraction comparison between the average Ct
value of the target and the average Ct value of the endogenous control for a sample.

8

Statistical analysis
Demographic data was collected from participants by survey at the time of blood
collection. Significance of the demonstrated tendency towards AAAA and GGTT
combined genotypes was calculated by first calculating expected genotype outcomes
using the observed allele frequencies and then using a chi-squared test. Originally, we
intended to use paired analyses for ELISA and cDNA data, but the non-random
assortment of alleles in combination with demographic mismatches (all 3 non-white
homozygous participants had genotype AAAA) left too few pairs for powerful analysis,
so data was analyzed in genotype aggregates. Significance in IL-18 ELISA results was
analyzed using Student’s t-tests. No statistical methods were used on IL-1β ELISA
results due to the absence of IL-1β in the samples. Student’s t-tests were also used to
compare NLRP1 Ct values in the qPCR results. All statistical tests were performed using
Microsoft Excel.
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RESULTS
Our sample of 50 participants included 35 females and 15 males, comprising 70%
and 30% of the sample, respectively. There were 45 participants who identified as White,
2 who identified as Hispanic, and 3 who identified as Asian, comprising 90%, 4%, and
6% of the sample, respectively. There were 44 participants between the ages of 18-29, 4
between the ages of 30-39, none between the ages of 40-49, and 2 between the ages of
50-59, comprising 88%, 8%, 0%, and 4% of the sample, respectively. See Table 1.
Demographics
Sex

Race

Age

N = 50

(%)

Female

35

70%

Male

15

30%

White

45

90%

Hispanic

2

4%

Asian

3

6%

18-29

44

88%

30-39

4

8%

50-59

2

4%

Table 1. Sample demographics. Participants were largely white, female, and between 18-29 years of age.

Genotyping
Using TaqMan genotyping we determined that at SNP rs2670660, 11 participants
were homozygous AA, 27 participants were heterozygous AG, and 12 participants were
homozygous GG, comprising 22%, 54%, and 24% of the sample, respectively. This
resulted in allele frequencies at this SNP of 0.49 for A and 0.51 for G. Furthermore, we
determined that 11 participants were homozygous AA, 28 participants were heterozygous
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AT, and 11 participants were homozygous TT at SNP rs12150220, comprising 22%,
56%, and 22% of the sample, respectively. This resulted in allele frequencies at this SNP
of 0.50 for A and 0.50 for G. See Table 2.
Genotypes, n (%)
rs2670660

rs12150220

Alleles, frequency

AA

AG

GG

A

G

11 (22)

27 (54)

12 (24)

0.49

0.51

AA

AT

TT

A

T

11 (22)

28 (56)

11 (22)

0.50

0.50

Table 2. Genotypes and allele frequencies for rs2670660 and rs12150220 as calculated from sample.

When consolidated into combined genotypes, the genotype results of rs2670660
and rs12150220 show very strong indications of linkage (Table 3). (Combined genotypes
are written in this paper as the genotype at rs2670660 and then the genotype at
rs12150220. For example, genotype GGTT has homozygous GG at rs2670660 and
homozygous TT at rs12150220). Homozygous combined genotypes AAAA and GGTT
are strongly favored over homozygous combined genotypes AATT or GGAA, with 10
AAAA and 10 GGTT participants and zero AATT or GGAA participants. Mixed
homozygous/heterozygous combined genotypes were also rare, with 1 each of AAAT,
AGAA, and AGTT genotypes, and 2 of GGAT. There were 25 participants who were
heterozygous at both rs2670660 and rs12150220. If rs2670660 and rs12150220 were
assorting independently with the observed allele frequencies from Table 2, the expected
distribution of combined genotypes would be as follows for 50 samples: 3.001 AAAA,
6.248 AGAA, 3.251 GGAA, 6.003 AAAT, 12.495 AGAT, 6.503 GGAT, 3.001 AATT,
6.248 AGTT, and 3.251 GGTT. Comparing these expected values with the observed
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genotype results via a chi-squared test strongly disproves the null hypothesis, with a pvalue of 2.33 x 10-13. Thus, it can be asserted that rs2670660 and rs12150220 are coinherited or linked.

rs2670660, n (%)
AA

AG

GG

rs12150220, AA

10 (20)

1 (2)

0 (0)

n (%)

AT

1 (2)

25 (50)

2 (4)

TT

0 (0)

1 (2)

10 (20)

Table 3. Combined genotypes of rs2670660/rs12150220 show strong linkage. AAAA and GGTT are
the strongest homozygous combined genotypes, with no AATT or GGAA homozygous combined
genotypes present. There are also more heterozygotes than would be expected in independent assortment
based on the observed allele frequencies. P = 2.33 x 10-13.

Cytokine analysis
The IL-18 ELISA produced significant results in the combined genotype
comparison as well as at each SNP. In the combined genotype comparison, the average
concentrations for each genotype were as follows (samples were run in duplicate): GGTT
= 0.152 ng/µL (SE = 0.021, n = 10); AAAA = 0.439 ng/µL (SE = 0.116, n = 10); AAAT
= 0.124 ng/µL (n = 1); GGAT = 0.106 ng/µL (SE = 0.026, n = 2); AGAA = 0.104 ng/µL
(n = 1); AGTT = 0.2005 ng/µL (n = 1). Only AAAA and GGTT combined genotypes
were deemed to have sufficient quantity for statistical analysis, and a Student’s T-test
found that the concentration of IL-18 was significantly higher in the AAAA genotype
than the GGTT genotype (p = 0.024). See Figure 3a.
The combined genotypes were subdivided back into SNP genotypes for
comparisons between homozygous individuals at each SNP, incorporating those that had
12

mixed combined genotypes. In the comparison for rs2670660, the average concentrations
for each homozygous genotype were 0.145 ng/µL for GG (SE = 0.018, n = 24) and 0.410
ng/µL for AA (SE = 0.107, n = 22). A Student’s T-test found significance at the level of
p = 0.022 for this comparison. See Figure 3b.
In the comparison for rs12150220, the average concentrations for each
homozygous genotype were 0.157 ng/µL for TT (SE = 0.019, n = 22) and 0.408 ng/µL
for AA (SE = 0.107, n = 22). A Student’s T-test found significance at the level of p =
0.030 for this comparison. See Figure 3c.
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a)
*

IL-18 Concentration ng/µL

0.6
0.5
0.4
0.3
0.2
0.1
0
GGTT

AAAA

AAAT

GGAT

AGAA

Combined Genotype

b)

IL-18 Concentration ng/µL

0.7

*

0.6
0.5
0.4
0.3
0.2
0.1
0
GG

AA

rs2670660 Genotype

(Figure 3. See legend on next page.)
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AGTT

c)

IL-18 Concentration ng/µL

0.6

*

0.5
0.4
0.3
0.2
0.1
0
TT

AA

rs12150220 Genotype
Figure 3. Significantly higher concentrations of IL-18 displayed in AAAA combined genotype and
individual AA genotypes. a) Comparison of IL-18 concentrations across all present combined genotypes.
*p = 0.024 for AAAA vs. GGTT. Statistical significance was not calculated for other combined genotypes due
to small sample sizes. b) Comparison of IL-18 concentrations for variants of rs2670660 homozygous samples.
*p = 0.022 for AA vs. GG. c) Comparison of IL-18 concentrations for variants of rs12150220 homozygous
samples. *p = 0.030 for AA vs. TT.

The IL-1β ELISA did not produce any significant results for any of the samples.
All sample concentrations were unmeasurable (<0.000 ng/µL) but the standards worked
as expected (Figure 4), validating the sample results.
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Figure 4. Standard curve of IL-1β demonstrates functional ELISA. No samples showed measurable
concentrations of IL-1β. However, the standards worked as anticipated, demonstrating the accuracy of
the non-measurements.

NLRP1 gene expression
Quantitative PCR was used to determine differences in NLRP1 gene expression.
The qPCR showed a trend towards earlier amplification in the AAAA genotype, with
earlier amplification indicating higher gene expression (Figure 5). GAPDH was used as
an endogenous control, but some GAPDH samples had unusual melt curves, perhaps
indicating poor primers. The correct shape of NLRP1 melt curves indicates that the
NLRP1 primers functioned properly (Figure 6). Since an analysis using ∆Ct scores
calculated with GAPDH did not show different trends than an analysis using only NLRP1
Ct scores, NLRP1 Ct scores were used for comparison between NLRP1 combined
genotypes to avoid any complications from the unusual melting of some GAPDH
samples. One sample of redundant demographics and genotype (GGTT) was excluded
from this analysis, and all other samples were run in duplicate and then averaged for each
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sample. The mean NLRP1 Ct scores were as follows for each combined genotype: AAAA
= 33.237 (n = 10); GGTT = 35.382 (n = 9); AGTT = 28.735 (n = 1); AAAT = 37.651 (n
= 1); AGAA = 29.876 (n = 1); GGAT = 30.031 (n = 2). There is no statistically
significant difference between the means of the AAAA and GGTT genotypes (p = 0.101).
However, due to the exponential nature of Ct calculations, the difference in means of
2.135 represents a 4.392-fold increase in gene expression, and the lower Ct value
represents the higher gene expression. Therefore, these results demonstrate a trend
towards higher gene expression in genotype AAAA when compared to genotype GGTT.
Combined genotypes AGTT, AAAT, AGAA, and GGAT were not statistically analyzed
due to small sample sizes (Figure 7). An analysis of homozygous genotypes for
rs2670660 found the average NLRP1 Ct score for AA to be 33.247 (n = 11) and for GG
to be 34.046 (n = 11), and an analysis of homozygous genotypes for rs12150220 found
the average of NLRP1 Ct score for AA to be 32.941 (n = 11) and for TT to be 34.717 (n =
11).
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a)

b)

c)

d)

Figure 5: Amplification plots indicate a trend towards earlier amplification in NLRP1 AAAA
combined genotype. a) qPCR amplification plot of NLRP1 AAAA genotype displays some earlier
amplification compared to b) qPCR amplification plot of NLRP1 GGTT genotype. c) GAPDH AAAA
genotype control shows consistent amplification with two outliers. d) GAPDH GGTT genotype control
shows consistent amplification with two outliers. Significance threshold for qPCR set to ∆Rn = 0.048564.
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Figure 6: Example of unusual GAPDH melt curve in comparison with normal NLRP1 melt curve. The
qPCR melt curves of GAPDH and NLRP1 are shown for one sample, number L48. A reliable melt curve
should only have one major peak, as seen in the results for NLRP1. The variety of peaks in the results for
GAPDH demonstrates the possibility of poor primers. These trends were typical across all samples.
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45
40

NLRP1 Ct score

35
30
25
20
15
10
5
0
AAAA

GGTT

AGTT

AAAT

AGAA

GGAT

Combined genotype

Figure 7: AAAA combined genotype trends towards higher gene expression than GGTT combined
genotype in qPCR. This box and whisker plot shows the median and interquartile range of Ct scores for the
NLRP1 qPCR, with whiskers extending to the full range of collected data. The mean for genotype AAAA is
33.237 and the mean for genotype GGTT is 35.382. There is no statistically significant difference between
these means (p = 0.10). Due to the exponential nature of Ct calculations, the difference in means of 2.135
represents a 4.392-fold increase in gene expression, and the lower Ct value represents the higher gene
expression. Therefore, these results may indicate a possible trend towards higher gene expression in genotype
AAAA when compared to genotype GGTT. Further analysis with more samples would be needed to provide
statistical power for this conclusion. Combined genotypes AGTT, AAAT, AGAA, and GGAT were not
statistically analyzed due to small sample sizes (n = 1, 1, 1, and 2, respectively).
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DISCUSSION
A variety of allele frequencies for rs2670660 and rs12150220 have been reported
across many large-scale analyses for different racial groups [23, 24]. As our sample
population was 90% White and located in the United States, comparisons to previous
study results from European and American cohorts are most demographically accurate.
Our allele frequencies are much closer to 0.50/0.50 at both SNPs than many of these
study results, which tend to favor the A variant of both SNPs in ratios that approach
0.60/0.40 [23, 24]. For example, in an gnomAD study of Americans, rs2670660 allele
frequencies were 0.57 for A and 0.43 for G [23].
There is consensus that the risk variant for autoimmune disease for rs12150220 is
A, however the literature is less clear concerning the risk variant for rs2670660 [8, 20,
25]. In a European population, Magitta et al. found variant A at rs2670660 to have a trend
of association with Addison’s disease and type 1 diabetes compared to healthy controls.
Therefore, it is possible that our AAAA combined genotype represents two homozygous
risk variants, with the GGTT combined genotype representing two homozygous
protective variants. The IL-18 precursor needs to be cleaved by caspase-1 to become
biologically active, and the NLRP1 protein recruits caspase-1 [2, 26]. In this context, the
significant increase in IL-18 concentration found in the AAAA genotype could be
indicative of an association between increased autoimmune risk and increased processing
of IL-18 by the NLRP1 inflammasome. The absence of results for the IL-1β ELISA are
not surprising for a sample population without diagnosed autoimmune disease, as
elevated levels of IL-1β production related to NLRP1 have only been observed in
autoimmune-presenting populations [11].
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rs12150220 is an L115H substitution located in the protein-coding region of
NLRP1, while rs2670660 is located in the promoter region [12]. As such, we would
expect rs2670660 to have more of an influence on levels of gene expression than
rs12150220. Although there was a trend towards higher NLRP1 expression in the samples
with AA genotypes at each SNP, our pPCR analysis was not sufficient to distinguish the
influence of each SNP on gene expression due to the strong linkage demonstrated in our
genotype analysis. If there were more intermediate combined genotypes—ex. AGAA or
AAAT—it would perhaps become possible to distinguish the effects of each locus on
gene expression.
Variants to several SNPs in the NLRP1 gene have been associated with increased
presentation of autoimmune disease [7]. Here we find that SNPs rs2670660 and
rs12150220 are strongly linked, and that combined genotype AAAA leads to an increased
presence of IL-18. Further analysis is needed to determine which NLRP1 SNPs are more
specifically implicated in an increase in IL-18 production and NLRP1 gene expression.
Several hundred samples, of both healthy participants and those with diagnosed
autoimmune diseases, should be collected and analyzed for cytokine production and
NLRP1 gene expression at several more risk-associated SNPs in addition to rs2670660
and rs12150220. Understanding the mechanisms of the NLRP1 gene and the NLRP1
inflammasome may give clues to the causes of autoimmune conditions, possibly one day
leading to improved health outcomes for the millions of people affected by these
conditions.
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